[18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer

BACKGROUND: Patients with hormone receptor-positive breast cancer typically show favorable survival. However, identifying individuals at high risk of recurrence among these patients is a crucial issue. We tested the hypothesis that [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Gwe, Lee, Minkyung, Jeon, Tae Joo, Han, Kyunghwa, Lee, Hak Min, Lee, Seung Ah, Ryu, Young Hoon, Son, Eun Ju, Jeong, Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148332/
https://www.ncbi.nlm.nih.gov/pubmed/25167062
http://dx.doi.org/10.1371/journal.pone.0105905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148332/
https://www.ncbi.nlm.nih.gov/pubmed/25167062
http://dx.doi.org/10.1371/journal.pone.0105905

Ejemplares similares